Updated Labeling for Vaping Products
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new labels for vaping products to better inform the public about nicotine content and emissions. Researchers aim to assess the effectiveness of various label designs in conveying this information. They seek input from U.S. youth aged 14-20 and adults 21 and over. Participants should either have no history of tobacco use or have used e-cigarettes and/or cigarettes in the past month. As an unphased trial, this study offers participants the opportunity to contribute to significant public health research that could influence future labeling standards.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on vaping and tobacco use, so it might not affect your medications.
What prior data suggests that these updated labels are safe for public use?
In a previous study, researchers created new labels for vaping products to help people better understand nicotine content and its effects. The goal is to make these labels clear for both young people and adults.
This trial does not involve testing a drug or medical device, so there are no safety concerns like side effects. It aims to evaluate the effectiveness of different product labels. Participants will simply view various label designs, which poses no risk.
The main focus is on improving awareness of nicotine content in e-cigarettes, not on testing a medical treatment. Therefore, there are no safety concerns typically associated with trials for new medications.12345Why are researchers excited about this trial?
Researchers are excited about the trial for updated labeling on vaping products because it explores how different label versions might impact consumer behavior and understanding. Unlike traditional labels, which often just list ingredients or warnings, the "Flux Label" versions aim to engage users more effectively by potentially altering font, imagery, or layout to capture attention and convey risks. By investigating these variations, researchers hope to find out which labeling strategies best communicate health risks and reduce vaping among consumers. This could lead to more effective public health messaging and safer consumer choices.
What evidence suggests that these updated labels are effective for conveying nicotine information?
This trial will compare different versions of updated labels for vaping products. Studies have shown that current labels on vaping products fail to clearly communicate nicotine levels to users. New labels are being developed to highlight the nicotine content and release rate. Research suggests these new labels could offer more accurate information than the current ones. In tests, labels that explain nicotine release rates have helped people better understand nicotine levels in various tobacco products. These improvements aim to help people make more informed choices about vaping products. Participants in this trial may be randomized to view Version 1, Version 2, or Version 3 of the flux label.12467
Are You a Good Fit for This Trial?
This trial is for people living in the U.S. who are either youth (ages 14-20) or adults (21+). Participants can be non-users, e-cigarette users, cigarette users, or those who use both. People must not have used tobacco products outside these categories.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Survey
Participants are surveyed to evaluate the utility of new nicotine labels
Follow-up
Participants are monitored for understanding and perception of nicotine strength and addictiveness
What Are the Treatments Tested in This Trial?
Interventions
- Updated Labeling
Trial Overview
The study is testing new labels for vaping products that show nicotine concentration and how much nicotine is released when using them. Researchers will survey participants to see if these new labels help people better understand nicotine content.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Participants may be randomized to view Version 3 of the flux label
Participants may be randomized to view Version 2 of the flux label
Participants may be randomized to view Version 1 of the flux label
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Citations
Updated Labeling in Nicotine Labeling for E-cigarettes
The primary hypothesis is that the new nicotine concentration and flux label(s) will outperform mg/mL market labeling in accurately conveying ...
Study Details | NCT07553585 | Novel Labels to Improve ...
The aims of this study include developing and validating two new types of labels for the nicotine in vaping products: nicotine concentration and ...
Updated Labeling for Vaping Products · Info for Participants
The aims of this study include developing and validating two new types of labels for the nicotine in vaping products: nicotine concentration and nicotine flux ( ...
Analysis of vaping substances for label accuracy, nicotine ...
Regulatory implementation led to partial improvements in product labelling and nicotine compliance, but noncompliance still persisted, ...
Comparison of nicotine emissions rate, 'nicotine flux', from ...
We found that for inhalable tobacco products, combustible cigarettes exhibited the greatest average nicotine flux, while waterpipes exhibited the greatest ...
Analysis of vaping substances for label accuracy, nicotine ...
A summary of label data from vape products purchased before, during and after regulations came into effect in New Zealand. Labelling, December 2020 Set #1 (109 ...
Nicotine Concentration and Nicotine Flux
Here, we propose to extend our work to develop two labels: 1) a nicotine concentration label that could replace all current FDA-required ENDS nicotine ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.